Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 147   

Articles published

BMY 51.67 +0.16 (0.31%)
price chart
Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer ...
Bristol-Myers expects a decision from the Food and Drug Administration on its nivolumab skin cancer treatment in mid 2015. The suit, filed Thursday in federal court in Wilmington, Delaware, is Bristol-Myers Squibb v. Merck & Co., 14-cv-01131, U.S ...
Daily Options Trading for Bristol-Myers Squibb Company (BMY)  AVAFIN
Bristol-Myers sues Merck over US immunotherapy patent  Reuters
Related articles »  
Deutsche Bank Starts Bristol-Myers Squibb Co. (BMY) at Hold
Deutsche Bank initiated coverage on Bristol-Myers Squibb Co. (NYSE: BMY) with a Hold rating and a price target of $52.00. Analyst Gregg Gilbert said, "We are initiating coverage of Bristol Myers Squibb (BMY) with a Hold rating and $52 target price.
Shining on Major News: Bristol-Myers Squibb Company (NYSE:BMY), Best Buy ...  WallStreet Scope
Wednesday's Analyst Moves: Pfizer Inc., Merck & Co., Inc., Bristol ...  Dividend.com
Related articles »  
Bristol-Myers Squibb Co (BMY) Sues Merck & Co., Inc. (MRK) Over Cancer Drug ...
Bristol-Myers Squibb Co (NYSE:BMY) along with Ono Pharmaceutical launched a lawsuit against Merck & Co., Inc. (NYSE:MRK) last Thursday, claiming that the company's new cancer drug Keytruba (which was approved by the FDA the same day) violates ...
Weekly Pharma Notes: Bristol-Myers Squibb, Johnson & Johnson, Merck And ...  Forbes
Volatile Stocks to Watch: Bristol-Myers Squibb Co (NYSE:BMY), Energy ...  Techsonian (press release)
Related articles »  
Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) � Bristol-Myers ...
Bristol-Myers Squibb Company (NYSE:BMY) [Business Wire] - Bristol-Myers Squibb Company will present at the Bank of America Merrill Lynch Global Health Care Conference on Thursday, September 18, 2014, in London.
Top News: Bristol-Myers Squibb Company (NYSE:BMY), United States Steel ...  Equities Focus (registration)
Insider Selling: Bristol-Myers Squibb SVP Sells 7415 Shares of Stock (BMY)  WKRB News
Related articles »  
Intercept Pharmaceuticals Inc. (ICPT), Bristol-Myers Squibb Co (BMY), Biogen ...
In Bristol-Myers Squibb Co (NYSE:BMY), Orbimed Advisors revealed holding 7.19 million shares, worth nearly $349 million. The stake represents an increase from 5.97 million shares the fund reported previously.
Related articles »  
Notable Movers � General Mills, (NYSE:GIS), Bristol-Myers Squibb Co (NYSE ...
Bristol-Myers Squibb Co (NYSE:BMY) reported that the European Commission has approved Daklinza (daclatasvir), a potent, pan-genotypic NS5A replication complex inhibitor (in vitro), for use in combination with other medicinal products across genotypes 1 ...
Trade-Ideas: Bristol-Myers Squibb Company (BMY) Is Today's "Storm The Castle ...
Trade-Ideas LLC identified Bristol-Myers Squibb Company ( BMY) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate.
Insider Selling: Bristol-Myers Squibb EVP Sells 63667 Shares of Stock (BMY)  WKRB News
Bristol-Myers CEO Sells $2.5 Million in Stock  Barron's
Related articles »  
Eye Catching Stocks: NVIDIA Corporation (NASDAQ:NVDA), Bristol-Myers ...
Bristol-Myers Squibb Company (NYSE:BMY) EVP Francis M. Cuss sold 63,667 shares of Bristol-Myers Squibb stock in a transaction dated Tuesday, September 16th.
Bristol-Myers Squibb Becomes #111 Most Shorted S&P 500 Component ...
In our new rank based on the most recent short interest data from NASDAQ, Bristol-Myers Squibb Co. (NYSE: BMY) has taken over the position of #111 most shorted S&P 500 component, from Vulcan Materials Co (NYSE: VMC) which is now in the #220 spot.
Related articles »  
Morning Alert: Caterpillar (NYSE:CAT), Bristol-Myers Squibb Company (NYSE ...
Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced charitable donations totaling more than $1 million to be granted between 2014 and 2016 to seven nonprofit organizations that support patients with cardiovascular disease.